Beyond the Data Surge: Governance, Platforms & Deal‑Readiness in Biotech
🚀 Beyond the Data Surge: Governance, Platforms & Deal-Readiness in Biotech
In today's biotech landscape, data is both our most valuable asset and our biggest vulnerability. From discovery to deal-making, startups are evaluated not only on their science but on how they manage, secure, and govern their data throughout its lifecycle.
💬 What does “good data governance” really mean in a biotech context? 💬 When should startups start building a data governance framework? 💬 What do investors look for in a well-structured data room, and how can founders prepare for due diligence with confidence?
Join us for an evening of practical insight and cross-sector dialogue exploring how biotech innovators can strengthen data integrity, compliance, and deal-readiness from day one!
🎯 Program Highlights
1️⃣ Seminars
Jeffrey Lim, Co-Managing Director, Joyce A. Tan & Partners
Eric M. Gifford, PhD, Senior Scientific Sales Executive, APAC, Collaborative Drug Discovery (CDD Vault)
2️⃣ Panel Discussion Moderator: Frederick Tay, Director, Joyce A. Tan & Partners Panelists:
Eric M. Gifford, PhD, Senior Scientific Sales Executive, APAC, Collaborative Drug Discovery (CDD Vault)
Jonathan Ang, Entrepreneur Partner, Polaris Partners
Dipti Thakkar, PhD, Chief Operating Officer, Hummingbird Bioscience
🗓 Date: Thursday, 6 November 2025 🕔 Time: 5:00 – 8:00 PM 📍 Venue: NSG BioLabs, 21 Biopolis Rd, #02-03/05 North Tower, Nucleos, Singapore 138567
This event is co-organized by CDD Vault, Joyce A. Tan & Partners, NSG BioLabs, and Biotech Connection Singapore.
Whether you’re a founder preparing for your next funding round, an investor evaluating biotech potential, or a scientist navigating compliance and IP considerations, this session will equip you with practical frameworks to turn data from a liability into a strategic advantage.
🚨 Seats are limited — register early to secure your spot!